EPS (Diluted) for Labcorp Holdings (LH)
According to Labcorp Holdings's latest reported financial statements, the company's current diluted EPS (TTM) is $10.46. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$10.46
YoY change
+18.3%
5Y CAGR
-8.0%
Peak year (2021)
$24.38
Latest annual
$10.46
EPS (Diluted) history chart for Labcorp Holdings (LH) from 1988 to 2025
EPS (Diluted) history table for Labcorp Holdings (LH) from 1988 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $10.46 | +18.3% | ||
| 2024 | $8.84 | +85.3% | ||
| 2023 | $4.77 | -65.8% | ||
| 2022 | $13.96 | -42.7% | ||
| 2021 | $24.38 | +53.5% | ||
| 2020 | $15.88 | +90.0% | ||
| 2019 | $8.36 | -2.9% | ||
| 2018 | $8.61 | -29.5% | ||
| 2017 | $12.21 | +73.9% | ||
| 2016 | $7.02 | +61.8% | ||
| 2015 | $4.34 | -26.6% | ||
| 2014 | $5.91 | -5.4% | ||
| 2013 | $6.25 | +4.3% | ||
| 2012 | $5.99 | +17.2% | ||
| 2011 | $5.11 | -3.4% | ||
| 2010 | $5.29 | +6.2% | ||
| 2009 | $4.98 | +8.3% | ||
| 2008 | $4.60 | +17.0% | ||
| 2007 | $3.93 | +21.3% | ||
| 2006 | $3.24 | +19.6% | ||
| 2005 | $2.71 | +10.6% | ||
| 2004 | $2.45 | +16.1% | ||
| 2003 | $2.11 | +19.2% | ||
| 2002 | $1.77 | +39.4% | ||
| 2001 | $1.27 | +56.8% | ||
| 2000 | $0.81 | +179.3% | ||
| 1999 | $0.29 | -42.0% | ||
| 1998 | $0.50 | -123.0% | ||
| 1997 | $-2.17 | -30.4% | ||
| 1996 | $-3.12 | +1055.6% | ||
| 1995 | $-0.27 | -130.0% | ||
| 1994 | $0.90 | -71.4% | ||
| 1993 | $3.15 | +191.7% | ||
| 1992 | $1.08 | -58.9% | ||
| 1991 | $2.63 | +26.4% | ||
| 1990 | $2.08 | +27.6% | ||
| 1989 | $1.63 | +30.4% | ||
| 1988 | $1.25 | — |
EPS (Diluted) values are taken from Labcorp Holdings's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Labcorp Holdings (LH) diluted EPS totalled $10.46 – grew 18.3% year-over-year.
Through 2020–2025 (5 years), Labcorp Holdings diluted EPS delivered a -8.0% annualised rate; sustaining 2 straight years of year-over-year growth.
Between 2021 and 2025, Labcorp Holdings diluted EPS plunged 57.1%, falling from $24.38 to $10.46.
$24.38 stands as the all-time-high annual diluted EPS, posted in 2021, against a low of $-3.12 during 1996.
Among 8 Healthcare peers, Labcorp Holdings (LH) ranks 7th; the peer median for diluted EPS is $13.16.
Labcorp Holdings EPS (Diluted) by Year
Labcorp Holdings EPS (Diluted) 2025: $10.46
Labcorp Holdings diluted EPS in 2025 was $10.46, grew 18.3% from 2024.
Labcorp Holdings EPS (Diluted) 2024: $8.84
Labcorp Holdings diluted EPS in 2024 was $8.84, surged 85.3% from 2023.
Labcorp Holdings EPS (Diluted) 2023: $4.77
Labcorp Holdings diluted EPS in 2023 was $4.77, plunged 65.8% below 2022.
Labcorp Holdings EPS (Diluted) 2022: $13.96
Labcorp Holdings diluted EPS in 2022 was $13.96, plunged 42.7% below 2021.
Labcorp Holdings EPS (Diluted) 2021: $24.38
Labcorp Holdings diluted EPS in 2021 was $24.38.
See more financial history for Labcorp Holdings (LH).
Sector peers — EPS (Diluted)
Companies in the same sector as Labcorp Holdings, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Labcorp Holdings's diluted EPS?
- Latest reported diluted EPS for Labcorp Holdings (LH) is $10.46 (period ending December 31, 2025).
How has Labcorp Holdings diluted EPS changed year-over-year?
- Labcorp Holdings (LH) diluted EPS changed +18.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Labcorp Holdings diluted EPS?
- Labcorp Holdings (LH) diluted EPS compound annual growth rate is -8.0% over the most recent 5 years available.
When did Labcorp Holdings diluted EPS hit its highest annual value?
- Labcorp Holdings diluted EPS reached its highest annual value of $24.38 in 2021.
What was Labcorp Holdings diluted EPS in 2024?
- Labcorp Holdings (LH) diluted EPS in 2024 was $8.84.
What was Labcorp Holdings diluted EPS in 2025?
- Labcorp Holdings (LH) diluted EPS in 2025 was $10.46.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LH Overview
Company profile, financial tools, and key metrics
LH Revenue Counter
Earns $442.41 every second. See per minute, hour, and day.
LH Earnings Counter
Earns $27.79 per second net profit. See per minute, hour, and day.
LH Economic Scale
Exceeds West Bank and Gaza's GDP. Compare with world economies.
LH What If Invested
What if you had invested $1,000? See historical returns from any date.
LH How It Makes Money
Discover visual breakdown of $13.95B in revenue — where it comes from and where it goes.
LH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LH Daily Price Character
Balanced · 47.4% historical win rate (green days). Streaks & record days.
LH Buybacks
2.17% TTM buyback yield. Shareholder yield & SBC comparison.
LH Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LH Dividend Profile
Yield: 1.12%. Safety: 4/6. See full history.
LH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.